LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 43

Search options

  1. Article ; Online: Symbiotic Beams: Using Non-microscopy Electron Sources to Bring LPTEM's Puzzles into Better Focus.

    Gibson, Wyeth / Mulvey, Justin / Patterson, Joe

    Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

    2023  Volume 29, Issue Supplement_1, Page(s) 1491–1492

    Language English
    Publishing date 2023-08-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 1385710-1
    ISSN 1435-8115 ; 1431-9276
    ISSN (online) 1435-8115
    ISSN 1431-9276
    DOI 10.1093/micmic/ozad067.766
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients.

    Mulvey, J Justin / Magro, Cynthia M / Ma, Lucy X / Nuovo, Gerard J / Baergen, Rebecca N

    publication RETRACTED

    Annals of diagnostic pathology

    2020  Volume 46, Page(s) 151529

    Keywords covid19
    Language English
    Publishing date 2020-04-25
    Publishing country United States
    Document type Journal Article ; Retracted Publication
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2020.151529
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.

    Magro, Cynthia / Nuovo, Gerard / Mulvey, J Justin / Laurence, Jeffrey / Harp, Joanna / Crowson, A Neil

    Clinics in dermatology

    2021  Volume 39, Issue 6, Page(s) 934–965

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a single-stranded RNA virus whose sequence is known. COVID-19 is associated with a heterogeneous clinical phenotype ranging from ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a single-stranded RNA virus whose sequence is known. COVID-19 is associated with a heterogeneous clinical phenotype ranging from asymptomatic to fatal disease. It appears that access to nasopharyngeal respiratory epithelia expressing angiotensin-converting enzyme (ACE) 2, the receptor for SARS-CoV-2, is followed by viral replication in the pulmonary alveolar septal capillary bed. We have demonstrated in earlier studies that incomplete viral particles, termed pseudovirions, dock to deep subcutaneous and other vascular beds, potentially contributing to the prothrombotic state and systemic complement activation that characterizes severe and critical COVID-19. A variety of skin eruptions have been described in the setting of SARS-CoV-2 infection and more recently, after COVID-19 vaccination. The vaccines deliver a laboratory-synthesized mRNA that encodes a protein that is identical to the spike glycoprotein of SARS-CoV-2, allowing the production of immunogenic spike glycoprotein that will then elicit T cell and B cell adaptive immune responses. In this contribution, we review an array of cutaneous manifestations of COVID-19 that provide an opportunity to study critical pathophysiologic mechanisms that underlie all clinical facets of COVID-19, ranging from asymptomatic/mild to severe and critical COVID-19. We classify cutaneous COVID-19 according to underlying pathophysiologic principles. In this regard we propose three main pathways: (1) complement mediated thrombotic vascular injury syndromes deploying the alternative and mannan binding lectin pathways and resulting in the elaboration of cytokines like interleukin 6 from endothelium in the setting of severe and critical COVID-19 and (2) the robust T cell and type I interferon-driven inflammatory and (3) humoral-driven immune complex mediated vasculitic cutaneous reactions observed with mild and moderate COVID-19. Presented are novel data on cutaneous vaccine reactions that manifest a clinical and morphologic parallel with similar eruptions observed in patients with mild and moderate COVID-19 and in some cases represent systemic eczematoid hypersensitivity reactions to a putative vaccine-based antigen versus unmasking subclinical hypersensitivity due to immune enhancing effects of the vaccine. Finally, we demonstrate for the first time the localization of human synthesized spike glycoprotein after the COVID-19 vaccine to the cutaneous and subcutaneous vasculature confirming the ability of SARS-CoV-2 spike glycoprotein to bind endothelium in the absence of intact virus.
    MeSH term(s) COVID-19/immunology ; COVID-19/physiopathology ; COVID-19 Vaccines ; Cytokines ; Humans ; Skin Diseases/immunology ; Skin Diseases/virology ; Spike Glycoprotein, Coronavirus
    Chemical Substances COVID-19 Vaccines ; Cytokines ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2021-07-22
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1064149-x
    ISSN 1879-1131 ; 0738-081X
    ISSN (online) 1879-1131
    ISSN 0738-081X
    DOI 10.1016/j.clindermatol.2021.07.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Historical ABO blood group discrepancy: a blessing in disguise to unravel a medical identity theft.

    Mulvey, J Justin / Matnani, Rahul / Cushing, Melissa M

    Transfusion

    2017  Volume 57, Issue 4, Page(s) 1096–1097

    Language English
    Publishing date 2017-04
    Publishing country United States
    Document type Letter
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.14052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.

    Mulvey, J Justin / Magro, Cynthia M / Ma, Lucy X / Nuovo, Gerard J / Baergen, Rebecca N

    Annals of diagnostic pathology

    2020  Volume 46, Page(s) 151530

    Abstract: COVID-19, the disease caused by the novel Coronavirus, SARS-CoV-2, is increasingly being recognized as a systemic thrombotic and microvascular injury syndrome that may have its roots in complement activation. We had the opportunity to study the placental ...

    Abstract COVID-19, the disease caused by the novel Coronavirus, SARS-CoV-2, is increasingly being recognized as a systemic thrombotic and microvascular injury syndrome that may have its roots in complement activation. We had the opportunity to study the placental pathology of five full-term births to COVID-19 patients. All five exhibited histology indicative of fetal vascular malperfusion characterized by focal avascular villi and thrombi in larger fetal vessels. Vascular complement deposition in the placentas was not abnormal, and staining for viral RNA and viral spike protein was negative. While all cases resulted in healthy, term deliveries, these findings indicate the systemic nature of COVID-19 infection. The finding of vascular thrombosis without complement deposition may reflect the systemic nature of COVID-19's procoagulant effects unrelated to systemic complement activation.
    MeSH term(s) Betacoronavirus/genetics ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/virology ; Female ; Humans ; Pandemics ; Placenta/virology ; Pneumonia, Viral/complications ; Pneumonia, Viral/virology ; Pregnancy ; RNA, Viral/genetics ; SARS-CoV-2 ; Thrombosis/etiology
    Chemical Substances RNA, Viral
    Keywords covid19
    Language English
    Publishing date 2020-04-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2020.151530
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy.

    Mulvey, J Justin / Magro, Cynthia / Chadburn, Amy

    Blood cells, molecules & diseases

    2017  Volume 69, Page(s) 38–42

    Abstract: The anaphylatoxins produced by an unbridled complement cascade in atypical hemolytic uremic syndrome (aHUS) can alter the leukocyte environment in tissues and peripheral blood, causing clinically significant eosinophilia. While the membrane attack ... ...

    Abstract The anaphylatoxins produced by an unbridled complement cascade in atypical hemolytic uremic syndrome (aHUS) can alter the leukocyte environment in tissues and peripheral blood, causing clinically significant eosinophilia. While the membrane attack complex and C5a anaphlatoxin can be suppressed with anti-C5 biologics, the production of C3a is still capable of driving a destructive hypereosinophilic syndrome in spite of anticomplement therapy. The side-effects of glucocorticoids in treating hypereosinophilic syndrome limit their therapeutic index in long-term treatment and this behooves the use of alternative strategies. While use of the anti-IL-5 antibody, mepolizumab, has been reported for treatment of primary hypereosinophilic syndromes off-label, its usage in the setting of complement-driven thrombotic microangiopathy has not been attempted. We report mepolizumab's rapid resolution of a glucocorticoid-resistant hypereosinophilic syndrome that caused multi-organ dysfunction in a patient with a complex immune diathesis. The patient's long standing TTP/aHUS disease activity, shown to have direct correlation with his eosinophil count, improved with anti-IL-5 therapy, suggesting a reciprocal enhancement between the conditions.
    MeSH term(s) Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Biomarkers ; Biopsy ; Bone Marrow/pathology ; Disease Susceptibility/immunology ; Drug Resistance ; Eosinophils/immunology ; Eosinophils/pathology ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Steroids/pharmacology ; Steroids/therapeutic use ; Thrombotic Microangiopathies/diagnosis ; Thrombotic Microangiopathies/drug therapy ; Thrombotic Microangiopathies/immunology ; Treatment Outcome
    Chemical Substances Antibodies, Monoclonal, Humanized ; Biomarkers ; Immunoglobulins, Intravenous ; Steroids ; mepolizumab (90Z2UF0E52)
    Language English
    Publishing date 2017-05-02
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1237083-6
    ISSN 1096-0961 ; 1079-9796
    ISSN (online) 1096-0961
    ISSN 1079-9796
    DOI 10.1016/j.bcmd.2017.04.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Analysis of complement deposition and viral RNA in placentas of COVID-19 patients

    Mulvey, J. Justin / Magro, Cynthia M. / Ma, Lucy X. / Nuovo, Gerard J. / Baergen, Rebecca N.

    Annals of Diagnostic Pathology

    2020  Volume 46, Page(s) 151530

    Keywords Pathology and Forensic Medicine ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2020.151530
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: WITHDRAWN

    Mulvey, J. Justin / Magro, Cynthia M. / Ma, Lucy X. / Nuovo, Gerard J. / Baergen, Rebecca N.

    Annals of Diagnostic Pathology

    A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients

    2020  Volume 46, Page(s) 151529

    Keywords Pathology and Forensic Medicine ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2020.151529
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient: A Distinctive Reaction Pattern Reflecting Iatrogenic Th2 to Th1 Milieu Reversal.

    Mulvey, Joseph Justin / Nuovo, Gerard J / Magro, Cynthia M

    The American Journal of dermatopathology

    2016  Volume 38, Issue 7, Page(s) 492–498

    Abstract: A 70-year-old white man with stage C chronic lymphocytic leukemia who was being successfully treated with ibrutinib and rituximab developed bilateral, purpuric, painful cutaneous nodules. Biopsies of these nodules did not reveal the usual Th2 milieu of ... ...

    Abstract A 70-year-old white man with stage C chronic lymphocytic leukemia who was being successfully treated with ibrutinib and rituximab developed bilateral, purpuric, painful cutaneous nodules. Biopsies of these nodules did not reveal the usual Th2 milieu of chronic lymphocytic leukemia but instead exhibited a Th1-rich lymphocytic infiltrate with resultant neutrophil and granulomatous inflammation. The eruption resolved with drug cessation emphasizing the potential importance of this drug in treating conditions associated with Th2 dysregulation.
    MeSH term(s) Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; B7-H1 Antigen/analysis ; Biomarkers, Tumor/analysis ; Biopsy ; Drug Administration Schedule ; Drug Eruptions/etiology ; Drug Eruptions/immunology ; Drug Eruptions/pathology ; Humans ; Iatrogenic Disease ; Immunoglobulins, Intravenous/administration & dosage ; Interleukin-10/analysis ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/immunology ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Male ; Neoplasm Staging ; Phenotype ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Rituximab/administration & dosage ; Skin/drug effects ; Skin/immunology ; Skin/pathology ; Th1 Cells/drug effects ; Th1 Cells/immunology ; Th2 Cells/drug effects ; Th2 Cells/immunology ; Time Factors ; Treatment Outcome
    Chemical Substances B7-H1 Antigen ; Biomarkers, Tumor ; CD274 protein, human ; IL10 protein, human ; Immunoglobulins, Intravenous ; Protein Kinase Inhibitors ; Pyrazoles ; Pyrimidines ; Interleukin-10 (130068-27-8) ; ibrutinib (1X70OSD4VX) ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2016-03-30
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 448469-1
    ISSN 1533-0311 ; 0193-1091
    ISSN (online) 1533-0311
    ISSN 0193-1091
    DOI 10.1097/DAD.0000000000000441
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage.

    Laurence, Jeffrey / Nuovo, Gerard / Racine-Brzostek, Sabrina E / Seshadri, Madhav / Elhadad, Sonia / Crowson, A Neil / Mulvey, J Justin / Harp, Joanna / Ahamed, Jasimuddin / Magro, Cynthia

    The American journal of pathology

    2022  Volume 192, Issue 9, Page(s) 1282–1294

    Abstract: Apart from autopsy, tissue correlates of coronavirus disease 2019 (COVID-19) clinical stage are lacking. In the current study, cutaneous punch biopsy specimens of 15 individuals with severe/critical COVID-19 and six with mild/moderate COVID-19 were ... ...

    Abstract Apart from autopsy, tissue correlates of coronavirus disease 2019 (COVID-19) clinical stage are lacking. In the current study, cutaneous punch biopsy specimens of 15 individuals with severe/critical COVID-19 and six with mild/moderate COVID-19 were examined. Evidence for arterial and venous microthrombi, deposition of C5b-9 and MASP2 (representative of alternative and lectin complement pathways, respectively), and differential expression of interferon type I-driven antiviral protein MxA (myxovirus resistance A) versus SIN3A, a promoter of interferon type I-based proinflammatory signaling, were assessed. Control subjects included nine patients with sepsis-related acute respiratory distress syndrome (ARDS) and/or acute kidney injury (AKI) pre-COVID-19. Microthrombi were detected in 13 (87%) of 15 patients with severe/critical COVID-19 versus zero of six patients with mild/moderate COVID-19 (P < 0.001) and none of the nine patients with pre-COVID-19 ARDS/AKI (P < 0.001). Cells lining the microvasculature staining for spike protein of severe acute respiratory syndrome coronavirus 2, the etiologic agent of COVID-19, also expressed tissue factor. C5b-9 deposition occurred in 13 (87%) of 15 patients with severe/critical COVID-19 versus zero of six patients with mild/moderate COVID-19 (P < 0.001) and none of the nine patients with pre-COVID-19 ARDS/AKI (P < 0.001). MASP2 deposition was also restricted to severe/critical COVID-19 cases. MxA expression occurred in all six mild/moderate versus two (15%) of 13 severe/critical cases (P < 0.001) of COVID-19. In contrast, SIN3A was restricted to severe/critical COVID-19 cases co-localizing with severe acute respiratory syndrome coronavirus 2 spike protein. SIN3A was also elevated in plasma of patients with severe/critical COVID-19 versus control subjects (P ≤ 0.02). In conclusion, the study identified premortem tissue correlates of COVID-19 clinical stage using skin. If validated in a longitudinal cohort, this approach could identify individuals at risk for disease progression and enable targeted interventions.
    MeSH term(s) Acute Kidney Injury ; Antiviral Agents ; Biopsy ; COVID-19 ; Complement Membrane Attack Complex ; Humans ; Interferon Type I ; Mannose-Binding Protein-Associated Serine Proteases ; Respiratory Distress Syndrome ; Spike Glycoprotein, Coronavirus ; Thrombosis
    Chemical Substances Antiviral Agents ; Complement Membrane Attack Complex ; Interferon Type I ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; MASP2 protein, human (EC 3.4.21.-) ; Mannose-Binding Protein-Associated Serine Proteases (EC 3.4.21.-)
    Language English
    Publishing date 2022-05-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2943-9
    ISSN 1525-2191 ; 0002-9440
    ISSN (online) 1525-2191
    ISSN 0002-9440
    DOI 10.1016/j.ajpath.2022.05.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top